Aktie A3C4QV MONTEREY INNOVATION ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Monterey Innovation Acquisition Corp. Nasdaq

Aktien

A3C4QV

US61240F2074

MTRYU

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index
Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
MONTEREY INNOVATION ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
Monterey Bio Acquisition Corporation Announces Board Changes
Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer
Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC
MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DK1D Aktie
  4. A3C4QV Aktie
  5. Nachrichten Monterey Innovation Acquisition Corp.
  6. Andere Sprachen